Autologous blood cell transplantation versus HLA-identical siblingtransplantation for acute myeloid leukemia in first complete remission:a registry study from the Center for International Blood and MarrowTransplantation Research.
Haematologica., Sep (2012)
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J. Clin. Oncol., Aug;30(22):2753-9 (2012)
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
N. Engl. J. Med., Apr;366(15):1371-81 (2012)
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
J. Clin. Oncol., May;30(14):1663-9 (2012)
Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.
Biol. Blood Marrow Transplant., Aug;18(8):1204-10 (2012)
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood., Apr;119(15):3512-22 (2012)
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) study.
Br. J. Haematol., May;157(4):507-10 (2012)
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
J. Clin. Oncol., Mar;30(7):751-7 (2012)
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
J. Pediatr. Hematol. Oncol., Dec;33(8):610-6 (2011)
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
Biol. Blood Marrow Transplant., Feb;18(2):280-8 (2012)
Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH.
Pediatr Blood Cancer., Jul;59(1):189-90 (2012)
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood., Sep;118(11):3080-7 (2011)
Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).
Blood., Jul;118(4):874-83 (2011)
Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung.
J. Pediatr. Hematol. Oncol., Apr;33(3):e127-31 (2011)
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J. Pediatr. Hematol. Oncol., Jan;34(1):e1-7 (2012)
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Pediatr Blood Cancer., Oct;57(4):569-77 (2011)
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
Nat. Genet., Mar;43(3):237-41 (2011)
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
J. Clin. Oncol., Aug;28(23):3730-8 (2010)
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.
Blood., Aug;116(7):1045-50 (2010)
Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall.
J. Thorac. Cardiovasc. Surg., Apr;139(4):e71-2 (2010)
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.
Blood., Jul;115(26):5312-21 (2010)
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Blood., Mar;115(9):1850-7 (2010)
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma.
Biol. Blood Marrow Transplant., Apr;16(4):525-32 (2010)
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.
Blood., Feb;115(7):1394-405 (2010)
Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
Biol. Blood Marrow Transplant., Feb;16(2):223-30 (2010)
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.
Biol. Blood Marrow Transplant., May;15(5):626-31 (2009)
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
JAMA., Jan;301(4):393-403 (2009)
HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.
Biol. Blood Marrow Transplant., Oct;14(10):1141-7 (2008)
Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy.
J. Clin. Oncol., Sep;26(26):4326-32 (2008)
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
J. Clin. Oncol., Aug;26(24):3971-8 (2008)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
Blood., Jun;111(12):5477-85 (2008)
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.
Bone Marrow Transplant., May;41(10):867-72 (2008)
Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.
J. Pediatr. Hematol. Oncol., Sep;29(9):627-32 (2007)
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Cancer Genet. Cytogenet., Jun;175(2):117-24 (2007)
Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J. Pediatr. Hematol. Oncol., Jun;29(6):369-75 (2007)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Blood., Aug;110(4):1397-400 (2007)
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes Chromosomes Cancer., Jul;46(7):684-93 (2007)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
Blood., May;109(10):4582-5 (2007)
Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol., May;59(6):847-53 (2007)
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood., Feb;109(3):926-35 (2007)
Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
J. Clin. Oncol., Jan;24(1):145-51 (2006)
Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?
Pediatr Blood Cancer., May;46(5):660-1 (2006)
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
Bone Marrow Transplant., Jan;37(2):135-41 (2006)
Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
J. Clin. Oncol., Oct;23(28):7032-42 (2005)
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leuk
Leukemia., May;19(5):734-40 (2005)
Pyrite or true gold? Case 1.
J. Pediatr. Hematol. Oncol., Feb;27(2):61 (2005)
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
J. Clin. Oncol., Sep;22(18):3798-804 (2004)
A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
Pediatr Blood Cancer., Aug;43(2):105-9 (2004)
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Leukemia., Mar;18(3):521-9 (2004)
Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders.
Bone Marrow Transplant., Feb;33(3):321-7 (2004)
The surgeon's role in pediatric orbital malignancies: an oncologist's perspective.
Ophthal Plast Reconstr Surg., Sep;19(5):340-4 (2003)
Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs.
Leuk. Res., Mar;26(3):311-6 (2002)
What is the definition of cure for aplastic anemia?
Acta Haematol., 103(1):16-8 (2000)
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study.
J. Pediatr. Hematol. Oncol., 20(3):229-33 (1998 May-Jun)
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
Blood., Feb;91(3):1021-8 (1998)
Bone marrow transplantation for severe aplastic anemia: has outcome improved?
Blood., Jul;90(2):858-64 (1997)
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.
Blood., Feb;89(4):1143-6 (1997)
Biology and treatment of acute lymphocytic leukemia in children.
Semin. Oncol., Feb;24(1):83-91 (1997)
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Cancer., May;75(10):2623-31 (1995)
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
N. Engl. J. Med., Nov;331(19):1253-8 (1994)
Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome.
Am J Pediatr Hematol Oncol., Aug;15(3):335-7 (1993)
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Cancer., May;71(9):2854-61 (1993)
Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial.
J. Immunother., May;11(4):274-85 (1992)
Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.
Bone Marrow Transplant., Feb;9(2):119-22 (1992)
Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.
Am J Pediatr Hematol Oncol., 12(4):411-24 (1990)
Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Haematol Blood Transfus., 33:193-7 (1990)
Long-term follow-up of parental adjustment following a child's death at home or hospital.
Cancer., Mar;63(5):988-94 (1989)
Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.
Am J Pediatr Hematol Oncol., 11(1):64-73 (1989)
Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.
J. Clin. Oncol., Dec;6(12):1851-5 (1988)
Utilization of hospice/home care in pediatric oncology. A national survey.
Cancer Nurs., Jun;9(3):102-7 (1986)
Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation.
J Clin Lab Immunol., Jan;16(1):17-22 (1985)
Methemoglobinemia in an infant treated with the folk remedy glycerited asafoetida.
Pediatrics., May;73(5):717-9 (1984)
A comparison study of parental adaptation following a child's death at home or in the hospital.
Pediatrics., Jan;71(1):107-12 (1983)
Protein-energy nutritional status of pediatric cancer patients.
Am. J. Clin. Nutr., Nov;34(11):2486-92 (1981)
Patterns of communication among pediatric patients with leukemia, parents, and physicians: prognostic disagreements and misunderstandings.
J. Pediatr., Sep;99(3):480-3 (1981)